AbCellera Biologics Inc. ABCL Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s increase (decrease) in other operating assets?
- AbCellera Biologics Inc. (ABCL) reported increase (decrease) in other operating assets of $1.74M in Q1 2026.
- How has AbCellera Biologics Inc.'s increase (decrease) in other operating assets changed year-over-year?
- AbCellera Biologics Inc.'s increase (decrease) in other operating assets increased by 123.8% year-over-year, from -$7.32M to $1.74M.
- What is the long-term trend for AbCellera Biologics Inc.'s increase (decrease) in other operating assets?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s increase (decrease) in other operating assets has grown at a -3.1% compound annual growth rate (CAGR), from -$18.25M to -$17.15M.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.